Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Ling Lin

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Nanobiotechnology|February 20, 2016
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexYu-Ling Lin, Chia-Hung Chen, Hsin-Yi Wu, et al.
Neoplasia (New York, N.Y.)|October 22, 2024
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumorLe Hien Giang, Kuo-Sheng Wu, Wei-Chung Lee, et al.
Journal of Translational Medicine|February 12, 2026
7,7"-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastomaYi-Shin Wu, Han-Huei Lin, Kuo-Sheng Wu, et al.
Cancers|November 13, 2021
The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular CarcinomaPo-Yueh Chen, Tsung-Jung Tsai, Hsin-Yi Yang, et al.
Biotechnology and Bioengineering|December 31, 2010
A unique and potent protein binding nature of liposome containing polyethylenimine and polyethylene glycol: a nondisplaceable propertyYen-Ku Liu, Yu-Ling Lin, Chia-Hung Chen, et al.
BMC Cancer|April 29, 2018
Development of a computational promoter with highly efficient expression in tumorsShu-Yi Ho, Bo-Hau Chang, Chen-Han Chung, et al.
Cancer Biology & Therapy|September 7, 2010
A fusion protein with the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A) is an antagonist of angiogenesis in cancer treatment: Simultaneous blocking of VEGF receptor-1 and 2Feng-Jen Tseng, Yu-Cheng Chen, Yu-Ling Lin, et al.
Frontiers in Cellular Neuroscience|August 7, 2023
Differential expression of GABA<sub>A</sub> receptor subunits δ and α6 mediates tonic inhibition in parvalbumin and somatostatin interneurons in the mouse hippocampusTzu-Hsuan Huang, Yi-Sian Lin, Chiao-Wan Hsiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2016
In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathwayYu-Ling Lin, Nu-Man Tsai, Cheng-Hao Hsieh, et al.
Gut|December 9, 2015
The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis BHui-Han Hu, Jessica Liu, Yu-Ling Lin, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Nanobiotechnology|February 20, 2016
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexYu-Ling Lin, Chia-Hung Chen, Hsin-Yi Wu, et al.
Neoplasia (New York, N.Y.)|October 22, 2024
RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumorLe Hien Giang, Kuo-Sheng Wu, Wei-Chung Lee, et al.
Journal of Translational Medicine|February 12, 2026
7,7"-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastomaYi-Shin Wu, Han-Huei Lin, Kuo-Sheng Wu, et al.
Cancers|November 13, 2021
The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular CarcinomaPo-Yueh Chen, Tsung-Jung Tsai, Hsin-Yi Yang, et al.
Biotechnology and Bioengineering|December 31, 2010
A unique and potent protein binding nature of liposome containing polyethylenimine and polyethylene glycol: a nondisplaceable propertyYen-Ku Liu, Yu-Ling Lin, Chia-Hung Chen, et al.
BMC Cancer|April 29, 2018
Development of a computational promoter with highly efficient expression in tumorsShu-Yi Ho, Bo-Hau Chang, Chen-Han Chung, et al.
Cancer Biology & Therapy|September 7, 2010
A fusion protein with the receptor-binding domain of vascular endothelial growth factor-A (VEGF-A) is an antagonist of angiogenesis in cancer treatment: Simultaneous blocking of VEGF receptor-1 and 2Feng-Jen Tseng, Yu-Cheng Chen, Yu-Ling Lin, et al.
Frontiers in Cellular Neuroscience|August 7, 2023
Differential expression of GABA<sub>A</sub> receptor subunits δ and α6 mediates tonic inhibition in parvalbumin and somatostatin interneurons in the mouse hippocampusTzu-Hsuan Huang, Yi-Sian Lin, Chiao-Wan Hsiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2016
In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathwayYu-Ling Lin, Nu-Man Tsai, Cheng-Hao Hsieh, et al.
Gut|December 9, 2015
The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis BHui-Han Hu, Jessica Liu, Yu-Ling Lin, et al.
Pageof 10